These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Development and Validation of a Novel Questionnaire for Adherence with Topical Treatments in Psoriasis (QATOP). Teixeira A; Oliveira C; Teixeira M; Rita Gaio A; Lobo JMS; de Almeida IFM; Almeida V Am J Clin Dermatol; 2017 Aug; 18(4):571-581. PubMed ID: 28321796 [TBL] [Abstract][Full Text] [Related]
11. Pharmionics in dermatology: a review of topical medication adherence. Lee IA; Maibach HI Am J Clin Dermatol; 2006; 7(4):231-6. PubMed ID: 16901183 [TBL] [Abstract][Full Text] [Related]
13. Topical treatment of psoriasis: questionnaire results on topical therapy accessibility and influence of body surface area on usage. Iversen L; Lange MM; Bissonette R; Carvalho AVE; van de Kerkhof PC; Kirby B; Kleyn CE; Lynde CW; van der Walt JM; Wu JJ J Eur Acad Dermatol Venereol; 2017 Jul; 31(7):1188-1195. PubMed ID: 28370534 [TBL] [Abstract][Full Text] [Related]
14. Topical corticosteroids in plaque psoriasis: a systematic review of efficacy and treatment modalities. Castela E; Archier E; Devaux S; Gallini A; Aractingi S; Cribier B; Jullien D; Aubin F; Bachelez H; Joly P; Le Maître M; Misery L; Richard MA; Paul C; Ortonne JP J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():36-46. PubMed ID: 22512679 [TBL] [Abstract][Full Text] [Related]
15. Patients with psoriasis have different preferences for topical therapy, highlighting the importance of individualized treatment approaches: randomized phase IIIb PSO-INSIGHTFUL study. Hong CH; Papp KA; Lophaven KW; Skallerup P; Philipp S J Eur Acad Dermatol Venereol; 2017 Nov; 31(11):1876-1883. PubMed ID: 28796913 [TBL] [Abstract][Full Text] [Related]
16. Are ointments better than other vehicles for corticosteroid treatment of psoriasis? Zivkovich AH; Feldman SR J Drugs Dermatol; 2009 Jun; 8(6):570-2. PubMed ID: 19537382 [TBL] [Abstract][Full Text] [Related]
17. Expert recommendations: the use of the fixed combination calcipotriol and betamethasone dipropionate gel for the topical treatment of psoriasis. Daudén E; Bewley A; Lambert J; Girolomoni G; Cambazard F; Reich K J Eur Acad Dermatol Venereol; 2014 May; 28 Suppl 2():22-32. PubMed ID: 24684740 [TBL] [Abstract][Full Text] [Related]
18. Treatment adherence: a hurdle for real-life effectiveness in psoriasis? Reich K; Daudén E J Eur Acad Dermatol Venereol; 2014 May; 28 Suppl 2():1-3. PubMed ID: 24684737 [No Abstract] [Full Text] [Related]
19. Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy. Castela E; Archier E; Devaux S; Gallini A; Aractingi S; Cribier B; Jullien D; Aubin F; Bachelez H; Joly P; Le Maître M; Misery L; Richard MA; Paul C; Ortonne JP J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():47-51. PubMed ID: 22512680 [TBL] [Abstract][Full Text] [Related]
20. Long-term adherence to topical psoriasis treatment can be abysmal: a 1-year randomized intervention study using objective electronic adherence monitoring. Alinia H; Moradi Tuchayi S; Smith JA; Richardson IM; Bahrami N; Jaros SC; Sandoval LF; Farhangian ME; Anderson KL; Huang KE; Feldman SR Br J Dermatol; 2017 Mar; 176(3):759-764. PubMed ID: 27664969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]